Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Dermatology

Expert Opinion / Commentary · November 30, 2019

2019 Top Stories in Dermatology: Corporatization and the Rise of Private Equity in Dermatology

Written by
Jane M. Grant-Kels MD, FAAD

 

 Save  Recommend
 Share

Additional Info

  1. Konda S, Francis J, Motaparthi K, Grant-Kels JM. Future considerations for clinical dermatology in the setting of 21st century American policy reform: corporatization and the rise of private equity in dermatology. J Am Acad Dermatol. 2019;81(1):287-296.
  2. Hafner K. Why Private Equity is Furious Over a Paper in a Dermatology Journal.
  3. Casalino LP, Saini R, Bhidya S, et al. Private equity acquisition of physician practices. Ann Intern Med. 2019;170(2):114-115.
  4. Gondi S, Song Z. Potential implications of private equity investments in health care delivery. JAMA. 2019;321(11):1047-1048.
  5. Resneck JS Jr. Dermatology practice consolidation fueled by private equity investment: potential consequences for the specialty and patients. JAMA Dermatol. 2018;154(1):13-14.
  6. Tan S, Seiger K, Renehan P, et al. Trends in private equity acquisition of dermatology practices in the United States. JAMA Dermatol. 2019 Jul 24. doi: 10.1001/jamadermatol.2019.1634. [Epub ahead of print.]
  7. Sharfstein JM, Slocum J. Private equity and dermatology–first, do no harm. JAMA Dermatol. 2019 Jul 24. doi: 10.1001/jamadermatol.2019.1322. [Epub ahead of print.]
  8. Hafner P. Skin cancers rise along with questionable treatments. New York Times. 2017 (11/20/2017).
  9. Whoriskey P, Keating D. Overdoses, bedsores, broken bones: what happened when a private-equity firm sought to care for society’s most vulnerable. The Washington Post. November 25, 2018. Last accessed October 10, 2019.
  10. Dubb S. How Private Equity Drove the Nation’s Second-Largest Nursing Home Chain into the Ground. November 27, 2018. Last accessed October 10, 2019.
  11. Creswell J, Abelson R, Sanger-Katz M. The company behind many surprise emergency room bills. The New York Times. July 24, 2017. Last accessed October 10, 2019.
  12. Sanger-Katz M, Creswell J, Abelson R. Mystery Solved: Private-Equity backed firms are behind ad-blitz on “Surprise billing.” The New York Times. Last accessed 10/10/19
  13. Relman AS. The new medical-industrial complex. N Engl J Med. 1980;303(17):963-970.

  14. DeWane M, Mostow E, Grant-Kels JM. The corporatization of care in academic dermatology. Clin Dermatology. [In press.]

Disclosure statements are available on the authors' profiles:

Jane Grant-Kels MD, FAAD

Further Reading

Most Read This Week

Recently Updated